| Product Name | MF | CAS | Details |
|---|
| Influenza virus-IN-6 | C27H26ClNO7 | 2919303-26-5 | Details |
| Calpain Inhibitor XI | C19H29N3O4 | 145731-49-3 | Details |
| Thrombin inhibitor 6 | C18H19ClN4O2S | 1628224-94-1 | Details |
| Z-LE(OMe)TD(OMe)-FMK | C30H43FN4O11 | 210344-93-7 | Details |
| Kallikrein 5-IN-2 | C23H22N6O | 2361160-57-6 | Details |
| Anticancer agent 99 | C19H20F3N3O2 | 2914922-83-9 | Details |
| SARS-CoV-2 Mpro-IN-6 | C18H18Cl3N3O2S | 2768834-48-4 | Details |
| (R)-PD 0325901CL | C16H14ClF2IN2O4 | 1003216-77-0 | Details |
| GnRH-R antagonist 1 | C31H28F5N7O6S | 2826273-90-7 | Details |
| Umbralisib tosylate | C38H32F3N5O6S | 1532533-72-4 | Details |
| Niclosamide sodium | C13H9Cl2N2NaO4 | 40321-86-6 | Details |
| HIV-1 inhibitor-50 | C24H18FN5O2 | 2834087-69-1 | Details |
| Mcl-1 inhibitor 9 | C32H39ClN2O5S | 1883727-31-8 | Details |
| Antimalarial agent 20 | C31H38N4O3 | 1422207-75-7 | Details |
| EFdA-TP tetrasodium | 2883783-00-2 | Details |
| AT1R antagonist 1 | C28H32F3N5O4S2 | 2848719-80-0 | Details |
| 6-Fluoromevalonate | C6H9FO3 | 2822-77-7 | Details |
| AChE/Nrf2 modulator 1 | C27H27FN4O2 | 2417117-84-9 | Details |
| Endomorphin 1 acetate | C36H42N6O7 | 1276123-71-7 | Details |
| Ferroptosis inducer-1 | C25H21ClN2O5 | 2375357-96-1 | Details |
| LIMK1 inhibitor BMS-4 | C23H23N7O2S | 905298-84-2 | Details |
| IRE1α kinase-IN-7 | C28H25F3N6O | 1414938-22-9 | Details |
| iNOS inhibitor-10 | C22H23N3O2S | 2918773-63-2 | Details |
| SIRT5 inhibitor 5 | C21H14ClN3O3S | 2883730-60-5 | Details |
| Anticancer agent 66 | C26H23Cl2FN6O2S2 | 2691895-64-2 | Details |
| Antitumor agent-87 | C22H28N2O6S | 1422527-88-5 | Details |
| Anticancer agent 25 | C37H45BrN2O3 | 2401013-08-7 | Details |
| Palmatine hydroxide | C21H22NO4.HO | 131-04-4 | Details |
| Sirtuin modulator 4 | C18H10N2O2S | 327104-77-8 | Details |
| Crozbaciclib fumarate | C32H34F2N6O4 | 2567494-39-5 | Details |
| CBB1007 hydrochloride | C27H34N8O4.5ClH | 2070014-96-7 | Details |
| IL-17 modulator 5 | C28H23F6N9O2 | 2724206-27-1 | Details |
| (R)-Elsubrutinib | C17H19N3O2 | 1643570-23-3 | Details |
| c-Myc inhibitor 9 | C27H31N5OS | 2799717-96-5 | Details |
| Antitumor agent-81 | C19H19N7O3 | 2765180-17-2 | Details |
| HIV-1 inhibitor-53 | C30H34N2O8S | 2883496-10-2 | Details |
| Antiviral agent 23 | C18H21N5O4 | 35940-03-5 | Details |
| PRRSV/CD163-IN-1 | C25H24FN5O5S2 | 560995-89-3 | Details |
| GLS1 Inhibitor-4 | C29H27F3N10O2S2 | 2768599-97-7 | Details |
| PD-1/PD-L1-IN-26 | C43H52N4O8 | 2966090-78-6 | Details |
| c-Myc inhibitor 8 | C19H12BrClF3NO3S2 | 2173505-97-8 | Details |
| CB1 inverse agonist 2 | C24H20ClFN2OS | 1019839-52-1 | Details |
| Sortilin antagonist 1 | C20H24N2O4 | 2691846-93-0 | Details |
| GCGR antagonist 2 | C28H26N4O2 | 280134-25-0 | Details |
| GR 89696 free base | C19H25Cl2N3O3 | 126766-31-2 | Details |
| Efflux inhibitor-1 | C28H25N5O3 | 1776055-29-8 | Details |
| A3AR antagonist 2 | C22H16N6O3 | 1144161-05-6 | Details |
| Umbralisib sulfate | C31H26F3N5O7S | 1532533-75-7 | Details |
| LRRK2/NUAK1/TYK2-IN-1 | C20H11F3N6 | 2629192-96-5 | Details |
| P-gp inhibitor 4 | C38H38N2O8S2 | 2652001-05-1 | Details |
| RORγt inhibitor 2 | C31H33F5N2O7S | 2673278-10-7 | Details |
| PD-1/PD-L1-IN-27 | C44H35NO6 | 2891831-47-1 | Details |
| SARS-CoV-2-IN-12 | C32H42F3N5O9 | 2721455-52-1 | Details |
| A2AR-antagonist-1 | C27H25N5O2 | 2922920-71-4 | Details |
| URAT1 inhibitor 4 | C27H20BrN3O4S3 | 2700292-02-8 | Details |
| PfGSK3/PfPK6-IN-2 | C24H25Cl2N5OS | 2797225-47-7 | Details |
| Lapatinib tosylate | C36H34ClFN4O7S2 | 1187538-35-7 | Details |
| A1AT modulator 2 | C27H22FN3O3 | 2555004-05-0 | Details |
| Multi-kinase-IN-1 | C35H36F2N6O6S | 2470807-67-9 | Details |
| ERK-IN-2 free base | C16H17N5O2 | 2743576-55-6 | Details |
| Cefepime chloride | C19H25ClN6O5S2 | 107648-79-3 | Details |
| Lck Inhibitor III | C25H30N6O4 | 1188890-30-3 | Details |
| SARS-CoV MPro-IN-2 | C13H10O4 | 81418-42-0 | Details |
| Plm IV inhibitor-2 | C39H54N4O4 | 1539276-38-4 | Details |
| 3-Oxo-hop-22(29)-ene | C30H48O | 25615-11-6 | Details |
| Anticancer agent 53 | C31H25FN4O6S | 1926985-18-3 | Details |
| Isoandrographolide | C20H30O5 | 4176-96-9 | Details |
| MRS2279 diammonium | C13H21ClN6O8P2 | 2387505-47-5 | Details |
| GLP-1R agonist 17 | C28H26ClFN4O4S | 2749609-28-5 | Details |
| LTB4 antagonist 1 | C26H23NO6 | 2929239-84-7 | Details |
| RORγt modulator 5 | C27H22F5N3O6S | 2119042-65-6 | Details |
| 4-Formylcolchicine | C23H25NO7 | 2730-82-7 | Details |
| HIV-1 inhibitor-52 | C46H72FNO5S | 1818868-23-3 | Details |
| Antitumor agent-88 | C23H30N2O7S | 1422527-87-4 | Details |
| Dihydroaltenuene B | C15H18O6 | 887751-89-5 | Details |
| KRAS G12D inhibitor 3 | C34H31ClF3N5O2 | 2757095-11-5 | Details |
| LDC4297 hydrochloride | C23H29ClN8O | 2319747-14-1 | Details |
| (S)-LY3177833 hydrate | C16H14FN5O2 | 2733342-93-1 | Details |
| Aliskiren fumarate | C34H57N3O10 | 1196835-68-3 | Details |
| Dihydro-β-erythroidine | C16H21N1O3 | 23255-54-1 | Details |
| STING modulator-3 | C18H17N9O | 2839639-94-8 | Details |
| Anticancer agent 100 | C18H20ClN3O | 2914922-73-7 | Details |
| GPR84 antagonist 2 | C28H18Cl2NaO4PS2 | 2244269-74-5 | Details |
| Antioxidant agent-2 | C23H26N2O7 | 2250106-92-2 | Details |
| ATX inhibitor 17 | C29H29F5N8S | 2750152-64-6 | Details |
| BTK inhibitor 20 | C37H42N8O4 | 2696450-27-6 | Details |
| PARP11 inhibitor ITK7 | C17H14N4OS | 2411890-36-1 | Details |
| PI3K/mTOR Inhibitor-5 | C32H40N10O3 | 2456295-60-4 | Details |
| 5-Cyclopropylpentanal | C8H14O | 147159-38-4 | Details |
| HIV-1 inhibitor-10 | C39H54O6 | 1449660-81-4 | Details |
| Aurora Kinases-IN-3 | C20H16F3N3O4 | 2840558-83-8 | Details |
| Transketolase-IN-2 | C18H9F3N2O3S | 2757552-21-7 | Details |
| Axl/Mer/CSF1R-IN-1 | C25H24F3N5O5 | 2394874-60-1 | Details |
| IACS-8779 disodium | C21H26N9NaO10P2S2 | 2243079-27-6 | Details |
| Broussochalcone A | C20H20O5 | 99217-68-2 | Details |
| Tubulin inhibitor 30 | C22H19N3O5 | 2873383-67-4 | Details |
| STING modulator-4 | C17H18N8O | 2839639-72-2 | Details |
| NOD1/2 antagonist-1 | C32H28ClF5N4O4 | 2704623-69-6 | Details |
| PI3K/mTOR Inhibitor-13 | C20H13F2N5O3S | 1621718-37-3 | Details |
| IL-17A modulator-3 | C34H50FN7O4 | 2467732-95-0 | Details |
| Product Total： Product Page： | ||||
| 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 | ||||